{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T11:53:49Z","timestamp":1791287629208,"version":"4.1.0"},"reference-count":104,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:00:00Z","timestamp":1791244800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>Drug resistance continues to pose a significant challenge, accounting for a large proportion of relapses and playing a major role in cervical cancer-related mortality worldwide. Emerging evidence has indicated that the aberrant expression of non-coding RNAs, especially circular RNAs (circRNAs), long non-coding RNAs (lncRNAs), and microRNAs (miRNAs) is responsible for drug resistance, which poses a significant challenge to the success of chemotherapy. Addressing drug resistance is crucial for improving patient outcomes and reducing the burden of cervical cancer on healthcare systems. In this review, we summarize the molecular and cellular mechanisms through which circRNAs, miRNAs and lncRNAs mediate drug resistance to common drugs used in the treatment of cervical cancer. This work underscores non-coding RNAs as a promising therapeutic target, offering a potential avenue for overcoming chemoresistance in cervical cancer.<\/jats:p>","DOI":"10.3389\/fonc.2026.1913768","type":"journal-article","created":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T11:21:30Z","timestamp":1791285690000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Chemoresistance in cervical cancer: identifying and exploiting non-coding RNAs"],"prefix":"10.3389","volume":"16","author":[{"given":"Lilian","family":"Makgoo","sequence":"first","affiliation":[{"name":"Department of Biochemistry, Microbiology and Biotechnology, University of Limpopo","place":["Polokwane, South Africa"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zukile","family":"Mbita","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Microbiology and Biotechnology, University of Limpopo","place":["Polokwane, South Africa"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,10,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1541452","article-title":"Cervical cancer burden and attributable risk factors across different age and regions from 1990 to 2021 and future burden prediction: results from the global burden of disease study 2021","volume":"15","author":"Cheng","year":"2025","journal-title":"Front Oncol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1177\/25151355251356646","article-title":"Cervical cancer trends, HPV vaccine utilization, and screening in low-and lower-middle-income countries: an updated review","volume":"13","author":"Hamid","year":"2025","journal-title":"Ther Adv Vaccines Immunotherapy"},{"key":"B3","doi-asserted-by":"publisher","first-page":"155136","DOI":"10.1016\/j.prp.2024.155136","article-title":"Cervical cancer: novel treatment strategies offer renewed optimism","volume":"254","author":"Srinivasan","year":"2024","journal-title":"Pathol Res Pract"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.tvr.2022.200238","article-title":"Cervical cancer therapies: Current challenges and future perspectives","volume":"13","author":"Burmeister","year":"2022","journal-title":"Tumour Virus Res"},{"key":"B5","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.advms.2024.11.001","article-title":"Targeting treatment resistance in cervical cancer: a new avenue for senolytic therapies","volume":"70","author":"Meyer","year":"2025","journal-title":"Adv Med Sci"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-023-00612-3","article-title":"Advances in the structure, mechanism and targeting of chemoresistance-linked ABC transporters","volume":"23","author":"Sajid","year":"2023","journal-title":"Nat Rev Cancer"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2020.145000","article-title":"Rucaparib antagonize multidrug resistance in cervical cancer cells through blocking the function of ABC transporters","volume":"759","author":"Chen","year":"2020","journal-title":"Gene"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.113345","article-title":"Cellular landscaping of cisplatin resistance in cervical cancer","volume":"153","author":"Bhattacharjee","year":"2022","journal-title":"Biomedicine Pharmacotherapy"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.tox.2021.152762","article-title":"Involvement of ABC transporters in the detoxification of non-substrate nanoparticles in lung and cervical cancer cells","volume":"455","author":"Yuan","year":"2021","journal-title":"Toxicology"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.2147\/dddt.s106412","article-title":"Molecular mechanisms of cisplatin resistance in cervical cancer","volume":"10","author":"Zhu","year":"2016","journal-title":"Drug Des Dev Ther"},{"key":"B11","doi-asserted-by":"publisher","first-page":"4046","DOI":"10.12659\/msm.909452","article-title":"Cervical cancer cell growth, drug resistance, and epithelial-mesenchymal transition are suppressed by \u03b3-Secretase inhibitor RO4929097","volume":"24","author":"Wang","year":"2018","journal-title":"Med Sci Monitor"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddl046","article-title":"Non-coding RNA","volume":"15","author":"Mattick","year":"2006","journal-title":"Hum Mol Genet"},{"key":"B13","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s13045-019-0748-z","article-title":"Noncoding RNAs in cancer therapy resistance and targeted drug development","volume":"12","author":"Wang","year":"2019","journal-title":"J Hematol Oncol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ncrna.2016.12.001","article-title":"Non-coding RNAs: a tale of junk turning into treasure","volume":"1","author":"Ahmad","year":"2017","journal-title":"Non-coding RNA Res"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1002\/2211-5463.70088","article-title":"Non\u2010coding RNAs as key player in cancer diagnosis and treatment","volume":"15","author":"Majka","year":"2025","journal-title":"FEBS Open Bio"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2023.101730","article-title":"Unlocking the potential of non-coding RNAs in cancer research and therapy","volume":"35","author":"Uppaluri","year":"2023","journal-title":"Transl Oncol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/s41392-022-00975-3","article-title":"Targeting non-coding RNAs to overcome cancer therapy resistance","volume":"7","author":"Chen","year":"2022","journal-title":"Signal Transduction Targeted Ther"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.951864","article-title":"Non-coding RNA in cancer drug resistance: underlying mechanisms and clinical applications","volume":"12","author":"Zhou","year":"2022","journal-title":"Front Oncol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.1060909","article-title":"The role of long noncoding RNAs in therapeutic resistance in cervical cancer","volume":"10","author":"Zhou","year":"2022","journal-title":"Front Cell Dev Biol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2024.1308730","article-title":"The role of long non-coding RNAs and circular RNAs in cervical cancer: modulating miRNA function","volume":"12","author":"Heidari-Ezzati","year":"2024","journal-title":"Front Cell Dev Biol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(93)90529-y","article-title":"The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14","volume":"75","author":"Lee","year":"1993","journal-title":"Cell"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3390\/ijms14010480","article-title":"Recent insights and novel bioinformatics tools to understand the role of microRNAs binding to 5'untranslated region","volume":"14","author":"Da Sacco","year":"2012","journal-title":"Int J Mol Sci"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.4331\/wjbc.v8.i1.45","article-title":"Role of microRNAs in translation regulation and cancer","volume":"8","author":"Oliveto","year":"2017","journal-title":"World J Biol Chem"},{"key":"B24","doi-asserted-by":"publisher","first-page":"2999","DOI":"10.1073\/pnas.0307323101","article-title":"Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers","volume":"101","author":"Calin","year":"2004","journal-title":"Proc Natl Acad Sci"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13051168","article-title":"The role of microRNAs in the cisplatin-and radio-resistance of cervical cancer","volume":"13","author":"Masadah","year":"2021","journal-title":"Cancers"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.rpor.2018.09.002","article-title":"Chemotherapy and molecular therapy in cervical cancer","volume":"23","author":"Porras","year":"2018","journal-title":"Rep Pract Oncol Radiotherapy"},{"key":"B27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/B978-0-443-28985-9.00017-3","article-title":"An overview of cervical cancer, chemotherapy as treatment and chemotherapy resistance","volume-title":"Strategies for Overcoming Chemotherapy Resistance in Cervical Cancer","author":"Mbodi","year":"2024"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.2174\/1871520620666200224093301","article-title":"Current treatment for cervical cancer: an update","volume":"20","author":"Sharma","year":"2020","journal-title":"Anti-Cancer Agents Medicinal Chem (Formerly Curr Medicinal Chemistry-Anti-Cancer Agents)"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.891652","article-title":"Multidrug resistance in cancer: understanding molecular mechanisms, immunoprevention and therapeutic approaches","volume":"12","author":"Emran","year":"2022","journal-title":"Front Oncol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/s41586-019-1730-1","article-title":"A view on drug resistance in cancer","volume":"575","author":"Vasan","year":"2019","journal-title":"Nature"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.m804612200","article-title":"MicroRNA-221\/222 confers tamoxifen resistance in breast cancer by targeting p27Kip1*\u2666","volume":"283","author":"Miller","year":"2008","journal-title":"J Biol Chem"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2025.140134","article-title":"MiRNA-155: A double-edged sword in colorectal cancer progression and drug resistance mechanisms","volume":"299","author":"Hussen","year":"2025","journal-title":"Int J Biol Macromol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1015541107","article-title":"MicroRNA-21 induces resistance to 5-fluorouracil by down-regulating human DNA MutS homolog 2 (hMSH2)","volume":"107","author":"Valeri","year":"2010","journal-title":"Proc Natl Acad Sci"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2867-13-21","article-title":"miR-125b develops chemoresistance in Ewing sarcoma\/primitive neuroectodermal tumor","volume":"13","author":"Iida","year":"2013","journal-title":"Cancer Cell Int"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1002\/path.3997","article-title":"Glucocorticoid regulation of a novel HPV\u2013E6\u2013p53\u2013miR\u2010145 pathway modulates invasion and therapy resistance of cervical cancer cells","volume":"228","author":"Shi","year":"2012","journal-title":"J Pathol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0109299","article-title":"miR-375 mediated acquired chemo-resistance in cervical cancer by facilitating EMT","volume":"9","author":"Shen","year":"2014","journal-title":"PLoS One"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2013.308","article-title":"miR-375 is upregulated in acquired paclitaxel resistance in cervical cancer","volume":"109","author":"Shen","year":"2013","journal-title":"Br J Cancer"},{"key":"B38","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1002\/gcc.22006","article-title":"Focal aberrations indicate EYA2 and hsa\u2010miR\u2010375 as oncogene and tumor suppressor in cervical carcinogenesis","volume":"52","author":"Bierkens","year":"2013","journal-title":"Genes Chromosomes Cancer"},{"key":"B39","doi-asserted-by":"crossref","first-page":"6344","DOI":"10.7150\/jca.61194","article-title":"LncRNA MALAT1 was regulated by HPV16 E7 independently of pRB in cervical cancer cells","volume":"12","author":"Wang","year":"2021","journal-title":"J Cancer"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1155\/2023\/6341011","article-title":"Effect of Exosomal lncRNA MALAT1\/miR\u2010370\u20103p\/STAT3 positive feedback loop on PI3K\/Akt pathway mediating cisplatin resistance in cervical cancer cells","volume":"2023","author":"Hu","year":"2023","journal-title":"J Oncol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"6506","DOI":"10.12659\/msm.910969","article-title":"MicroRNA-7-5p promotes cisplatin resistance of cervical cancer cells and modulation of cellular energy homeostasis by regulating the expression of the PARP-1 and BCL2 genes","volume":"24","author":"Yang","year":"2018","journal-title":"Med Sci Monitor"},{"key":"B42","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.yexcr.2013.10.014","article-title":"MicroRNA-181a enhances the chemoresistance of human cervical squamous cell carcinoma to cisplatin by targeting PRKCD","volume":"320","author":"Chen","year":"2014","journal-title":"Exp Cell Res"},{"key":"B43","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.abb.2017.05.001","article-title":"Modulation of CASC2\/miR-21\/PTEN pathway sensitizes cervical cancer to cisplatin","volume":"623","author":"Feng","year":"2017","journal-title":"Arch Biochem Biophys"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2008.06.007","article-title":"Role of microRNA miR-27a and miR-451 in the regulation of MDR1\/P-glycoprotein expression in human cancer cells","volume":"76","author":"Zhu","year":"2008","journal-title":"Biochem Pharmacol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.73.11.3852","article-title":"Viroids are single-stranded covalently closed circular RNA molecules existing as highly base-paired rod-like structures","volume":"73","author":"Sanger","year":"1976","journal-title":"Proc Natl Acad Sci"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1261\/rna.064394.117","article-title":"Cardiac circRNAs arise mainly from constitutive exons rather than alternatively spliced exons","volume":"24","author":"Aufiero","year":"2018","journal-title":"Rna"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-019-03345-5","article-title":"CircRNA: a rising star in gastric cancer","volume":"77","author":"Li","year":"2020","journal-title":"Cell Mol Life Sci"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1080\/15476286.2017.1367886","article-title":"Circular RNAs: isolation, characterization and their potential role in diseases","volume":"14","author":"Liu","year":"2017","journal-title":"RNA Biol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12061472","article-title":"The expression, functions and mechanisms of circular RNAs in gynecological cancers","volume":"12","author":"Dong","year":"2020","journal-title":"Cancers"},{"key":"B50","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/s41568-024-00721-7","article-title":"Circular RNA in cancer","volume":"24","author":"Conn","year":"2024","journal-title":"Nat Rev Cancer"},{"key":"B51","doi-asserted-by":"publisher","first-page":"102286","DOI":"10.1016\/j.omtn.2024.102286","article-title":"The multifaceted roles of circular RNAs in cancer hallmarks: from mechanisms to clinical implications","volume":"35","author":"Kundu","year":"2024","journal-title":"Mol Ther Nucleic Acids"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1038\/s41580-020-0243-y","article-title":"The expanding regulatory mechanisms and cellular functions of circular RNAs","volume":"21","author":"Chen","year":"2020","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.20517\/cdr.2024.195","article-title":"Circular RNAs modulate cancer drug resistance: advances and challenges","volume":"8","author":"Hua","year":"2025","journal-title":"Cancer Drug Resistance"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.2217\/epi-2017-0055","article-title":"Screening circular RNA related to chemotherapeutic resistance in breast cancer","volume":"9","author":"Gao","year":"2017","journal-title":"Epigenomics"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1097\/cad.0000000000001365","article-title":"Exosomal circRNA Scm-like with four malignant brain tumor domains 2 (circ-SFMBT2) enhances the docetaxel resistance of prostate cancer via the microRNA-136-5p\/tribbles homolog 1 pathway","volume":"33","author":"Tan","year":"2022","journal-title":"Anti-Cancer Drugs"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.673237","article-title":"Exosomes mediated transfer of Circ_0000337 contributes to cisplatin (CDDP) resistance of esophageal cancer by regulating JAK2 via miR-377-3p","volume":"9","author":"Zang","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.108957","article-title":"Hsa_circ_0023404 enhances cervical cancer metastasis and chemoresistance through VEGFA and autophagy signaling by sponging miR-5047","volume":"115","author":"Guo","year":"2019","journal-title":"Biomedicine Pharmacotherapy"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.109064","article-title":"circMTO1 promotes tumorigenesis and chemoresistance of cervical cancer via regulating miR-6893","volume":"117","author":"Chen","year":"2019","journal-title":"Biomedicine Pharmacotherapy"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29270","article-title":"Circular RNA circMTO1 acts as the sponge of microRNA\u20109 to suppress hepatocellular carcinoma progression","volume":"66","author":"Han","year":"2017","journal-title":"Hepatology"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/5435333","article-title":"Circular RNA circ_0004488 increases cervical cancer paclitaxel resistance via the miR\u2010136\/MEX3C signaling pathway","volume":"2022","author":"Yi","year":"2022","journal-title":"J Oncol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.17945","article-title":"USF1 regulated circPRDM4 modulates tumorigenesis and immune escape in chemoresistant cervical cancer","volume":"28","author":"Zhang","year":"2024","journal-title":"J Cell Mol Med"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/4807287","article-title":"circ_ZFR Is Linked to Paclitaxel Resistance in Cervical Cancer via miR\u2010944 Sponging and IL\u201010 Upregulation","volume":"2022","author":"Long","year":"2022","journal-title":"Anal Cell Pathol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1080\/15384101.2023.2281768","article-title":"Exosome-delivered circRNA circSYT15 contributes to cisplatin resistance in cervical cancer cells through the miR-503-5p\/RSF1 axis","volume":"22","author":"Chen","year":"2023","journal-title":"Cell Cycle"},{"key":"B64","doi-asserted-by":"publisher","first-page":"5406","DOI":"10.18632\/aging.204152","article-title":"circEPSTI1 promotes tumor progression and cisplatin resistance via upregulating MSH2 in cervical cancer","volume":"14","author":"Wu","year":"2022","journal-title":"Aging (Albany NY)"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1002\/mc.23605","article-title":"Circ_0001589\/miR\u20101248\/HMGB1 axis enhances EMT\u2010mediated metastasis and cisplatin resistance in cervical cancer","volume":"62","author":"Ma","year":"2023","journal-title":"Mol Carcinog"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1038\/s41580-022-00566-8","article-title":"Long non-coding RNAs: definitions, functions, challenges and recommendations","volume":"24","author":"Mattick","year":"2023","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1128\/mcb.00528-19","article-title":"When long noncoding becomes protein coding","volume":"40","author":"Hartford","year":"2020","journal-title":"Mol Cell Biol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.4161\/rna.20481","article-title":"The hallmarks of cancer: a long non-coding RNA point of view","volume":"9","author":"Gutschner","year":"2012","journal-title":"RNA Biol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1038\/s41576-024-00693-2","article-title":"Targeting and engineering long non-coding RNAs for cancer therapy","volume":"25","author":"Coan","year":"2024","journal-title":"Nat Rev Genet"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1016\/j.ncrna.2022.07.003","article-title":"Long noncoding RNAs (lncRNAs) in HIV-mediated carcinogenesis: Role in cell homeostasis, cell survival processes and drug resistance","volume":"7","author":"Makgoo","year":"2022","journal-title":"Non-coding RNA Res"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1172\/jci84424","article-title":"Targeting non-coding RNAs in disease","volume":"127","author":"Adams","year":"2017","journal-title":"J Clin Invest"},{"key":"B72","doi-asserted-by":"publisher","first-page":"e27207","DOI":"10.1016\/j.heliyon.2024.e27207","article-title":"Long non-coding RNAs in drug resistance across the top five cancers: update on their roles and mechanisms","volume":"10","author":"Shi","year":"2024","journal-title":"Heliyon"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2023.147726","article-title":"Advances in long non-coding RNA regulating drug resistance of cancer","volume":"887","author":"Ying","year":"2023","journal-title":"Gene"},{"key":"B74","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s12943-020-01162-0","article-title":"Long non-coding RNAs regulate drug resistance in cancer","volume":"19","author":"Liu","year":"2020","journal-title":"Mol Cancer"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2015.04.121","article-title":"Overexpression of long non-coding RNA PVT1 in gastric cancer cells promotes the development of multidrug resistance","volume":"462","author":"Zhang","year":"2015","journal-title":"Biochem Biophys Res Commun"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.3233\/TUB-219010","article-title":"RETRACTED ARTICLE: Overexpression of long non-coding RNA HOTAIR leads to chemoresistance by activating the Wnt\/\u03b2-catenin pathway in human ovarian cancer","volume":"37","author":"Li","year":"2016","journal-title":"Tumor Biol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2016.521","article-title":"LncRNA HULC triggers autophagy via stabilizing Sirt1 and attenuates the chemosensitivity of HCC cells","volume":"36","author":"Xiong","year":"2017","journal-title":"Oncogene"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.117981","article-title":"Roles of long non-coding RNAs in cervical cancer","volume":"256","author":"Luo","year":"2020","journal-title":"Life Sci"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1089\/cbr.2016.2156","article-title":"Expression of long noncoding RNA urothelial cancer associated 1 promotes cisplatin resistance in cervical cancer","volume":"32","author":"Wang","year":"2017","journal-title":"Cancer Biother Radiopharm"},{"key":"B80","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1159\/000519844","article-title":"LncRNA HOTAIR promotes chemoresistance by facilitating epithelial to mesenchymal transition through miR-29b\/PTEN\/PI3K signaling in cervical cancer","volume":"211","author":"Zhang","year":"2022","journal-title":"Cells Tissues Organs"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1080\/1061186x.2017.1307379","article-title":"LncRNA PVT1 epigenetically silences miR-195 and modulates EMT and chemoresistance in cervical cancer cells","volume":"25","author":"Shen","year":"2017","journal-title":"J Drug Targeting"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.26355\/eurrev_201811_16382","article-title":"MALAT1 promotes cisplatin resistance in cervical cancer by activating the PI3K\/AKT pathway","volume":"22","author":"Wang","year":"2018","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"B83","doi-asserted-by":"publisher","first-page":"BSR20200533","DOI":"10.1042\/bsr20200533","article-title":"Inhibition of lncRNA-NEAT1 sensitizes 5-Fu resistant cervical cancer cells through de-repressing the microRNA-34a\/LDHA axis","volume":"41","author":"Shao","year":"2021","journal-title":"Biosci Rep"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.27198","article-title":"Suppression of long noncoding RNA NCK1\u2010AS1 increases chemosensitivity to cisplatin in cervical cancer","volume":"234","author":"Zhang","year":"2019","journal-title":"J Cell Physiol"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1111\/cbdd.14424","article-title":"LINC00460 knockdown sensitizes cervical cancer to cisplatin by downregulating TGFBI","volume":"103","author":"Tian","year":"2024","journal-title":"Chem Biol Drug Des"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1111\/jog.15245","article-title":"lncRNA DLG1\u2010AS1 promotes cervical cancer cell gemcitabine resistance by regulating miR\u201016\u20105p\/HDGF","volume":"48","author":"Zou","year":"2022","journal-title":"J Obstetrics Gynaecology Res"},{"key":"B87","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s12958-022-00995-2","article-title":"linc00958\/miR-185-5p\/RSF-1 modulates cisplatin resistance and angiogenesis through AKT1\/GSK3\u03b2\/VEGFA pathway in cervical cancer","volume":"20","author":"Tian","year":"2022","journal-title":"Reprod Biol Endocrinol"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2019.01.025","article-title":"Expression of the lncRNA ZFAS1 in cervical cancer and its correlation with prognosis and chemosensitivity","volume":"696","author":"Feng","year":"2019","journal-title":"Gene"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-895658\/v1","article-title":"Long Non-Coding RNA SNHG12 Contributes to Cisplatin Resistance by Mediating WEE1 via miR-503-5p in Cervical Cancer","author":"Dong","year":"2021"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2011.07.014","article-title":"A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language","volume":"146","author":"Salmena","year":"2011","journal-title":"Cell"},{"key":"B91","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1186\/s12935-021-02239-6","article-title":"Analyzing the whole-transcriptome profiles of ncRNAs and predicting the competing endogenous RNA networks in cervical cancer cell lines with cisplatin resistance","volume":"21","author":"Lv","year":"2021","journal-title":"Cancer Cell Int"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.883445","article-title":"Engineered exosomes-mediated transfer of hsa-miR-320a overcomes chemoresistance in cervical cancer cells via targeting MCL1","volume":"13","author":"Zhou","year":"2022","journal-title":"Front Pharmacol"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2026.1746979","article-title":"The role of long non-coding RNAs in therapy resistance of cervical cancer and therapeutic potential","volume":"14","author":"He","year":"2026","journal-title":"Front Cell Dev Biol"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1461894","article-title":"(Nano) biotechnological approaches in the treatment of cervical cancer: integration of engineering and biology","volume":"15","author":"Xie","year":"2024","journal-title":"Front Immunol"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.1036710","article-title":"Circulating miR-326 could serve as a predictive biomarker for response to neoadjuvant chemotherapy in locally advanced cervical cancer","volume":"12","author":"Zou","year":"2022","journal-title":"Front Oncol"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1177\/00368504251380636","article-title":"Effects of chemoradiotherapy on plasma oncogenic miRNAs as biomarkers in cervical cancer patients: a prospective observational study","volume":"108","author":"Parvizi","year":"2025","journal-title":"Sci Prog"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13225748","article-title":"Molecular markers to predict prognosis and treatment response in uterine cervical cancer","volume":"13","author":"Fleischmann","year":"2021","journal-title":"Cancers"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1019055108","article-title":"Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma","volume":"108","author":"Arroyo","year":"2011","journal-title":"Proc Natl Acad Sci"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0305050","article-title":"Identification of exosomal circSLC26A4 as a liquid biopsy marker for cervical cancer","volume":"19","author":"Tong","year":"2024","journal-title":"PLoS One"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1349474","article-title":"Exosomal noncoding RNAs in gynecological cancers: implications for therapy resistance and biomarkers","volume":"14","author":"Xu","year":"2024","journal-title":"Front Oncol"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.20517\/jtgg.2024.12","article-title":"The potential therapeutic applications of long non-coding RNAs","volume":"8","author":"Tamblin-Hopper","year":"2024","journal-title":"J Trans Genet Genomics"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-020-0802-1","article-title":"Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours","volume":"122","author":"Hong","year":"2020","journal-title":"Br J Cancer"},{"key":"B103","doi-asserted-by":"publisher","first-page":"552","DOI":"10.34172\/apb.025.45456","article-title":"siRNA and mRNA-based preventive and therapeutic strategies for HPV-induced cervical cancer","volume":"15","author":"Khari","year":"2025","journal-title":"Advanced Pharm Bull"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2023.1297413","article-title":"Advancing cancer treatment: in vivo delivery of therapeutic small noncoding RNAs","volume":"10","author":"Yang","year":"2024","journal-title":"Front Mol Biosci"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1913768\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T11:21:32Z","timestamp":1791285692000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1913768\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,6]]},"references-count":104,"alternative-id":["10.3389\/fonc.2026.1913768"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1913768","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,6]]},"article-number":"1913768"}}